Texas Permanent School Fund Eagle Pharmaceuticals, Inc. Transaction History

Texas Permanent School Fund

$597 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$25.06 - $34.09 $60,695 - $82,565	2,422 Added 35.02%	9,338 $264,000
Q4 2022 Feb 07, 2023	SELL	$24.98 - $39.77 $18,285 - $29,111	-732 Reduced 9.57%	6,916 $202,000
Q3 2022 Oct 25, 2022	SELL	$26.42 - $47.12 $11,941 - $21,298	-452 Reduced 5.58%	7,648 $202,000
Q2 2022 Aug 08, 2022	BUY	$41.26 - $51.35 $1,774 - $2,208	43 Added 0.53%	8,100 $360,000
Q1 2022 May 06, 2022	SELL	$44.58 - $52.6 $6,018 - $7,101	-135 Reduced 1.65%	8,057 $399,000
Q4 2021 Feb 08, 2022	SELL	$45.82 - $56.9 $15,303 - $19,004	-334 Reduced 3.92%	8,192 $417,000
Q3 2021 Oct 28, 2021	SELL	$43.79 - $55.78 $7,400 - $9,426	-169 Reduced 1.94%	8,526 $476,000
Q2 2021 Jul 27, 2021	BUY	$36.86 - $44.5 $1,142 - $1,379	31 Added 0.36%	8,695 $372,000
Q1 2021 May 03, 2021	SELL	$40.32 - $50.97 $26,127 - $33,028	-648 Reduced 6.96%	8,664 $362,000
Q4 2020 Feb 04, 2021	SELL	$41.72 - $51.34 $83,106 - $102,269	-1,992 Reduced 17.62%	9,312 $434,000
Q3 2020 Nov 06, 2020	BUY	$37.02 - $51.28 $122,277 - $169,377	3,303 Added 41.28%	11,304 $480,000
Q2 2020 Aug 04, 2020	SELL	$43.24 - $55.02 $22,744 - $28,940	-526 Reduced 6.17%	8,001 $384,000
Q1 2020 Apr 27, 2020	BUY	$34.37 - $60.07 $55,232 - $96,532	1,607 Added 23.22%	8,527 $392,000
Q4 2019 Feb 03, 2020	BUY	$54.32 - $64.31 $1,955 - $2,315	36 Added 0.52%	6,920 $416,000
Q3 2019 Oct 31, 2019	SELL	$53.25 - $59.98 $5,804 - $6,537	-109 Reduced 1.56%	6,884 $389,000
Q2 2019 Aug 09, 2019	SELL	$46.61 - $58.45 $139 - $175	-3 Reduced 0.04%	6,993 $389,000
Q1 2019 May 02, 2019	SELL	$38.66 - $51.82 $7,770 - $10,415	-201 Reduced 2.79%	6,996 $353,000
Q4 2018 Feb 11, 2019	BUY	$36.72 - $67.73 $6,866 - $12,665	187 Added 2.67%	7,197 $290,000
Q3 2018 Oct 22, 2018	BUY	$66.65 - $83.86 $109,172 - $137,362	1,638 Added 30.49%	7,010 $486,000
Q2 2018 Jul 23, 2018	SELL	$51.25 - $76.62 $8,200 - $12,259	-160 Reduced 2.89%	5,372 $406,000
Q1 2018 Apr 20, 2018	SELL	$52.16 - $66.86 $6,102 - $7,822	-117 Reduced 2.07%	5,532 $291,000
Q4 2017 Jan 23, 2018	SELL	$49.6 - $60.87 $28,569 - $35,061	-576 Reduced 9.25%	5,649 $302,000
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $290,209 - $375,741	6,225	6,225 $371,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.

Account